文献速递复苏、休克与脓毒症

King喉管与iGel声门上气道装置的回顾性比较:CARES监测组研究

A retrospective comparison of the King Laryngeal Tube and iGel supraglottic airway devices: A study for the CARES surveillance group.
PubMed 文献 · Resuscitation · 2023-04-28
一句话结论CARES数据回顾性分析显示,院外心脏骤停复苏中使用iGel与King喉管相比,神经功能良好生存率更高(aOR 1.45)。

本研究利用CARES公开研究数据集,纳入2013—2021年非创伤性院外心脏骤停且尝试EMS复苏的病例,比较King喉管与iGel两种声门上气道装置与神经功能结局的关联。采用以EMS机构为随机效应的两水平混合效应多因素logistic回归分析。主要终点为出院时脑功能分类(CPC)评分1或2的生存,iGel组优于King喉管组(aOR 1.45 [1.33, 1.58]);次要终点入院生存(1.07 [1.02, 1.12])和出院生存(1.35 [1.26, 1.46])也均优于King喉管组。作者认为,本研究进一步提示院外心脏骤停复苏中使用iGel与更好的结局相关。

要点

  • 院外心脏骤停EMS复苏使用iGel与King喉管相比,出院时CPC 1–2的生存更高(aOR 1.45 [1.33, 1.58])。
  • iGel组出院生存高于King喉管组(aOR 1.35 [1.26, 1.46])。
  • iGel组入院生存高于King喉管组(aOR 1.07 [1.02, 1.12])。
  • 分析纳入2013—2021年非创伤性院外心脏骤停且尝试EMS复苏的病例,校正年龄、性别、年份、初始心律、目击状态、旁观者CPR、反应间期和骤停地点。
  • 作者结论:院外心脏骤停复苏中使用iGel与优于King喉管的结局相关。

适用人群与场景

  • 2013—2021年CARES登记的非创伤性院外心脏骤停且尝试EMS复苏的病例。

研究设计与关键结果

  • 研究类型:基于CARES公开研究数据集的回顾性比较分析。
  • 主要终点:出院时脑功能分类(CPC)评分1或2的生存,使用iGel与King喉管相比aOR 1.45 [1.33, 1.58]。
  • 次要终点:入院生存aOR 1.07 [1.02, 1.12],出院生存aOR 1.35 [1.26, 1.46],均为iGel与King喉管比较。
  • 统计方法:以EMS机构为随机效应的两水平混合效应多因素logistic回归,校正年龄、性别、骤停日历年、初始心电图心律、目击状态(未目击、旁观者目击、9-1-1响应者目击)、旁观者CPR、反应间期和骤停地点(私人/家中、公共场所、机构)。

证据类型、等级与局限

  • 证据类型:回顾性比较研究(基于CARES登记数据)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,本研究进一步提示院外心脏骤停复苏中使用iGel与优于King喉管的结局相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: Supraglottic airway devices are increasingly used during the resuscitation of out-of-hospital cardiac arrest (OHCA) patients in the United States and worldwide. In this study, we aimed to compare the neurologic outcomes of OHCA patients managed with the King Laryngeal Tube (King LT) to the neurologic outcomes of patients managed with the iGel.

METHODS: We used the Cardiac Arrest Registry to Enhance Survival (CARES) public use research dataset for our analysis. Non-traumatic OHCA cases with attempted EMS resuscitation enrolled from 2013-2021 were included. We used two-level mixed effects multivariable logistic regression analyses with treating EMS agency as the random effect to determine the association between supraglottic airway device and outcome. The primary outcome was survival with a Cerebral Performance Category (CPC) score of 1 or 2 at discharge. Secondary outcomes included survival to hospital admission and survival to hospital discharge. Age, sex, calendar year of OHCA, initial ECG rhythm, witnessed status (unwitnessed, bystander witnessed, 9-1-1 responder witnessed), bystander CPR, response interval, and OHCA location (private/home, public, institutional) were used as covariables.

RESULTS: In comparison to use of the King LT, use of the iGel was associated with greater neurologically favorable survival (aOR: 1.45 [1.33, 1.58]). In addition, use of the iGel was associated with greater survival to hospital admission (1.07 [1.02, 1.12]) and survival to hospital discharge (1.35 [1.26, 1.46]).

CONCLUSIONS: This study adds to the body of literature suggesting that use of the iGel during OHCA resuscitation is associated with better outcomes than use of the King LT.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Smida T, Menegazzi J, Scheidler J, et al. A retrospective comparison of the King Laryngeal Tube and iGel supraglottic airway devices: A study for the CARES surveillance group. Resuscitation. 2023. PMID: 37120129. doi:10.1016/j.resuscitation.2023.109812

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。